Clinical Trial Update: Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC)

View source ↗

Summary

The study evaluating serum thioredoixn reductase activity in excised non-small cell lung cancers across stages I, II, and IIIA has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Non-small Cell Lung Cancer Stage I, Non-small Cell Lung Cancer Stage II | Status: COMPLETED